Respiratory Syncytial Virus Therapeutics Market Is Predicted to Reach More Than US $2100.0 Mn by 2025
The global Respiratory Syncytial Virus (RSV) Therapeutics Market was valued at approximately US$ 820.0 Mn in 2016 is projected to expand at a CAGR of more than 11.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Respiratory Syncytial Virus (RSV) Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that the rise in unmet medical needs within the antiviral therapy to treat RSV infection and...
View full press release